ICUI 82.38 Icu Medical $ICUI Hit a 52 week high of
Post# of 88793
![Avatar](/images/ProfileImages/563491128_9912_DennyT.jpg)
ICUI Recent Posts: http://investorshangout.com/ICU-Medical-Inc-ICUI-54414/
ICUI Icu Medical Recent Headline News
INSYS Therapeutics (INSY) in Focus: Stock Rises 12% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:44AM CST
INSYS Therapeutics, Inc. (INSY) was a big mover last session, as the company saw its shares surge 12%
ICUI: 83.23 (+2.36), INSY: 38.91 (-2.61), ABAX: 53.42 (-0.08), GWPH: 74.72 (-0.05)
ICU Medical Up 30.0% Since SmarTrend Uptrend Call (ICUI)
Comtex SmarTrend(R) - Tue Nov 11, 5:12PM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 30.02% as of today's recent price of $80.87.
ICUI: 83.23 (+2.36)
Nasdaq stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ICUI: 83.23 (+2.36), OREX: 5.99 (+0.95), PCMI: 8.91 (+0.01), CYAN: 5.92 (-0.14), ACHN: 13.13 (+0.65), TGTX: 13.26 (+0.35), AGIO: 87.08 (+5.17), LIOX: 5.44 (+0.01), SAJA: 6.25 (+0.65), PLNR: 6.93 (+0.12)
After Yesterday's Rally of 12.62% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Nov 11, 4:23PM CST
ICU Medical (NASDAQ:ICUI) traded in a range yesterday that spanned from a low of $80.15 to a high of $87.50. Yesterday, the shares gained 12.6%, which took the trading range above the 3-day high of $72.30 on volume of 950,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ICUI: 83.23 (+2.36)
Omnicell Reports Mixed Q3, Positive on Surgichem Buyout - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 2:00PM CST
On Nov 6, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.36 (-0.05), ICUI: 83.23 (+2.36), ABAX: 53.42 (-0.08), OMCL: 31.70 (+0.01)
Boston Scientific Shows Strength on Core Market Stabilization - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:50PM CST
On Nov 7, 2014, we issued an updated research report on leading medical devices company Boston Scientific Corporation (BSX).
BSX: 13.36 (-0.05), ICUI: 83.23 (+2.36), BCR: 164.11 (-0.16), ABAX: 53.42 (-0.08)
Midday gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 11:45AM CST
FSM: 4.30 (-0.12), HEAR: 4.06 (+0.09), JRJC: 7.38 (-0.11), CVO: 1.71 (+0.15), AAOI: 12.05 (+0.31), UNIS: 3.01 (+0.06), HIIQ: 8.65 (-0.58), CYAN: 5.92 (-0.14), PTX: 11.06 (-0.29), TRMR: 2.90 (+0.17), PRKR: 1.08 (-0.01), SUMR: 2.81 (+0.18), VSLR: 12.10 (+0.68), RVP: 3.97 (-0.16), ASCMA: 51.46 (+0.10), ICUI: 83.23 (+2.36), CALL: 8.52 (unch), DMD: 5.86 (-0.07), AST: 3.99 (+0.37), ASEI: 45.82 (-1.19)
Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:46AM CST
Eagle Pharmaceuticals (EGRX) was a big mover last session, with shares rising over 8% on the day.
ICUI: 83.23 (+2.36), ABAX: 53.42 (-0.08), GWPH: 74.72 (-0.05), EGRX: 12.81 (-0.72)
Upgrade Alert for ICU Medical (ICUI)
Comtex SmarTrend(R) - Tue Nov 11, 6:59AM CST
ICU Medical (NASDAQ:ICUI) was upgraded from Neutral to Buy at Roth Capital today. The stock closed yesterday at $71.81 on volume of 194,000 shares, above average daily volume of 126,000. ICU Medical share prices have moved between a 52-week high of $85.00 and a 52-week low of $35.58 and closed yesterday at 102% above that low price at $71.81 per share. The 200-day and 50-day moving averages have moved 0.16% higher and 0.83% higher over the past week, respectively.
ICUI: 83.23 (+2.36)
ICU Medical posts 3Q profit
Automated Insights - Tue Nov 11, 4:11AM CST
SAN CLEMENTE, Calif. (AP) _ ICU Medical Inc. (ICUI) on Tuesday reported profit of $6.4 million in its third quarter.
ICUI: 83.23 (+2.36)
ICU Medical's (ICUI) CEO Vivek Jain on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 6:51PM CST
ICUI: 83.23 (+2.36)
ICU Medical beats by $0.18, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:32PM CST
ICUI: 83.23 (+2.36)
ICU Medical (ICUI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST
ICUI: 83.23 (+2.36)
ICU Medical, Inc. Announces Third Quarter 2014 Results
GlobeNewswire - Mon Nov 10, 3:11PM CST
ICU Medical, Inc., (Nasdaq:ICUI) ("ICU Medical"
![](/images/icons/icon_wink.gif)
ICUI: 83.23 (+2.36)
Walgreens Hits the Rock with Court's Ruling on CFO Lawsuit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 2:30PM CST
The controversy surrounding an inflated fiscal 2016 earnings forecast continues for leading drugstore chain Walgreen Co. (WAG).
BSX: 13.36 (-0.05), ICUI: 83.23 (+2.36), ABAX: 53.42 (-0.08), WAG: 67.29 (-0.21)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:35PM CST
HK: 3.01 (-0.01), WWD: 50.96 (+2.26), LLNW: 2.72 (+0.03), FXEN: 2.76 (+0.04), RMTI: 10.95 (-0.20), CZR: 14.21 (+3.07), EGY: 7.14 (-0.05), ICUI: 83.23 (+2.36), ICEL: 7.54 (+0.01), SAAS: 8.88 (-0.18), DMD: 5.86 (-0.07), NPSP: 28.86 (-0.55), SCLN: 8.39 (+0.15), ATHX: 1.42 (-0.07), CMLS: 3.31 (-0.02), TC: 2.12 (-0.03), ATW: 35.57 (-0.68), CLUB: 6.09 (-0.05), RAX: 42.04 (-0.21), PTLA: 27.32 (+0.07), IPAR: 28.77 (-0.39), ATLS: 36.87 (-0.21), AMBC: 26.10 (+1.29), CUI: 7.95 (+0.06), PDLI: 8.03 (-0.08), OMER: 19.10 (+0.05), PRAA: 61.89 (+0.24), CARA: 8.16 (-0.32), HALO: 8.80 (-0.02), MODN: 10.47 (+0.01), CALL: 8.52 (unch), ASEI: 45.82 (-1.19), HGR: 20.10 (-0.43), ERII: 4.62 (+0.19)
BioScrip (BIOS) Q3 Loss Wider than Expected, Revenues Top - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:10PM CST
BioScrip, Inc. (BIOS) recently declared its third-quarter 2014 results.
BSX: 13.36 (-0.05), ICUI: 83.23 (+2.36), ABAX: 53.42 (-0.08), BIOS: 5.77 (+0.04)
Omnicell Earnings Hit by High Tax, User Addition Aids Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:27AM CST
On Nov 7, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.36 (-0.05), ICUI: 83.23 (+2.36), ABAX: 53.42 (-0.08), OMCL: 31.70 (+0.01)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)